For people with ischemic stroke, treatment with the clot-busting drug tenecteplase is associated with a slightly higher likelihood of an excellent recovery and reduced disability three months later than the drug alteplase, according to a meta-analysis published in the October 16, 2024, online issue of Neurology(r), the medical journal of the American Academy of Neurology. Researchers found that the likelihood of good recovery was similar between the two treatments.
Menu
Menu
